Related Experiment Video
Updated: Jun 21, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Bullatacin triggered ABCB1-overexpressing cell apoptosis via the mitochondrial-dependent pathway
Yong-Ju Liang1, Xu Zhang, Chun-Ling Dai
1State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, Guangzhou 510060, China.
Abstract:
This paper was to explore bullatacin-mediated multidrug-resistant cell apoptosis at extremely low concentration. To investigate its precise mechanisms, the pathway of cell apoptosis induced by bullatacin was examined. Bullatacin causes an upregulation of ROS and a downregulation of DeltaPsi(m) in a concentration-dependent manner in ABCB1-overexpressing KBv200 cells. In addition, cleavers of caspase-9, caspase-3, and PARP were observed following the release of cytochrome c from mitochondria after bullatacin treatment. However, neither cleavage of caspase-8 nor change of expression level of bcl-2, bax and Fas was observed by the same treatment. Pretreating KBv200 cells with N-acetylcysteine, an antioxidant modulator, resulted in a significant reduction of ROS generation and cell apoptosis induced by bullatacin. Bullatacin-induced apoptosis was antagonized by z-LEHD-fmk, a caspase-9 inhibitor, but not by z-IETD-fmk, a caspase-8 inhibitor. These implied that apoptosis of KBv200 cells induced by bullatacin was associated with the mitochondria-dependent pathway that was limited to activation of apical caspase-9.
Insights
Bullatacin induces apoptosis in multidrug-resistant cells via the mitochondria-dependent pathway. This process involves reactive oxygen species (ROS) and caspase-9 activation, highlighting a potential therapeutic target.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) in cancer cells poses a significant therapeutic challenge.
- Identifying novel agents that can overcome MDR and induce cancer cell death is crucial.
Purpose of the Study:
- To investigate the mechanisms of bullatacin-mediated apoptosis in multidrug-resistant cells.
- To explore the role of reactive oxygen species (ROS) and mitochondrial pathways in bullatacin-induced cell death.
Main Methods:
- Utilized ABCB1-overexpressing KBv200 cells to study bullatacin effects.
- Assessed reactive oxygen species (ROS) generation and mitochondrial membrane potential (DeltaPsi(m)).
- Analyzed caspase activation (caspase-9, caspase-3, caspase-8), PARP cleavage, and cytochrome c release.
Main Results:
- Bullatacin upregulated ROS and downregulated DeltaPsi(m) in a concentration-dependent manner.
- Observed cleavage of caspase-9, caspase-3, and PARP, indicating mitochondrial pathway activation.
- N-acetylcysteine pretreatment reduced ROS and apoptosis; caspase-9 inhibition blocked bullatacin-induced apoptosis.
Conclusions:
- Bullatacin induces apoptosis in multidrug-resistant cells through the mitochondria-dependent pathway.
- The mechanism involves ROS generation and subsequent activation of caspase-9.
- Bullatacin demonstrates potential as an agent to overcome multidrug resistance.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Caspases
